
Photobiomodulation (PBM) is an emerging method that uses light to improve mental well-being. This technique could offer a new approach to treating depression.
PBM uses low-intensity light to stimulate cells. By targeting the mitochondria, it improves cellular energy production, reduces inflammation, and promotes cell regeneration.
A comprehensive study titled "Review of Transcranial Photobiomodulation for Major Depressive Disorder: Targeting Brain Metabolism, Inflammation, Oxidative Stress, and Neurogenesis" was conducted by a team of researchers, including P. Cassano and Michael R. Hamblin. This research explores the use of photobiomodulation (PBM) to treat major depressive disorder (MDD).

The researchers used a systematic approach to examine the effects of red or near-infrared radiation on the brain. By focusing on clinical and preclinical studies, they sought to understand how PBM influences key biological processes such as brain metabolism, inflammation, oxidative stress, and neurogenesis.
Although promising, PBM remains experimental as a treatment for depression. Larger clinical trials are needed to confirm its efficacy and safety.
Consult a professional trained in PBM for a personalized assessment. This ensures appropriate and effective treatment.
References: Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.
Paolo Cassano, M.D., Samuel R. Petrie, Michael R. Hamblin, Theodore A. Henderson, M.D., Dan V. Iosifescu, M.D.
Our News